Article

CRISPR/Cas9 deletions induce adverse on-target genomic effects leading to functional DNA…

medRxiv · 2022 · Geng, K.; Merino, L. G.; Wedemann, L.; Martens, A.; Sobota, M.; Sanchez, Y. P.; Sondergaard, J. N.; White, R. J.; Kutter, C.

Key facts

Title CRISPR/Cas9 deletions induce adverse on-target genomic effects leading to functional DNA in human cells
First author Geng, K.; Merino, L. G.; Wedemann, L.; Martens, A.; Sobota, M.; Sanchez, Y. P.; Sondergaard, J. N.; White, R. J.; Kutter, C.
Journal medRxiv
Published Apr 25, 2022
DOI 10.1101/2021.07.01.450727
Devices mentioned K202641, K231013, K800781
Product codes mentioned KIS, QBD, MVU, PFF, PFT

At a glance

  • 1–9 FDA submissions mentioned
  • 1–9 Product codes mentioned

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About Literature

Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.

Source: Publisher and PubMed metadata; device mentions identified by Orca1

Browse all Literature